Congestive Heart Failure and Exposure to Children Increase RSV Risk in Adult COPD Patients
Spending time with children and congestive heart failure are associated with an increased risk for respiratory syncytial virus (RSV) infections among adults with chronic obstructive pulmonary disease (COPD), according to the results of a recent study.
The study, published in the June 2013 issue of COPD: Journal of Chronic Obstructive Pulmonary Disease, conducted a pooled analysis of data published in 2 previous studies to determine risk factors for developing serious RSV illness in adult patients with COPD. The 2 previous studies analyzed RSV infections in high-risk adults for 2 RSV seasons at most. The risk factors studied included age, sex, race, smoking status, exposure to children, home oxygen use, inhaled or oral steroid use, comorbid conditions, and the ability to perform everyday tasks. The researchers used logistic regression to identify significant risk factors for symptomatic and medically attended RSV infections.
A total of 379 COPD patients were included in the analysis, and 11% were diagnosed with symptomatic RSV infections. Approximately 47.6% of these adults with RSV infections required medical attention. In multivariate analyses, congestive heart failure and exposure to children were significantly associated with an increased risk for symptomatic RSV infections. For RSV infections severe enough to warrant medical attention, congestive heart failure was the only significant risk factor.
The authors of the study conclude that prospective studies are needed in the future to confirm exposure to children and congestive heart failure as risk factors and to identify other risk factors, including history of exacerbations, for RSV infections among adult COPD patients.
Articles in this issue
almost 12 years ago
Article
Financial Accruals in the Specialty Pharmaceutical Industry: The Case for Automating the Processalmost 12 years ago
Article
How Government Pricing Professionals Became Pharmaceutical Industry Change AgentsNewsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Related Articles
- Advise Patients About Self-Care Measures to Treat Mild to Moderate GI Issues
September 18th 2025
- Evaluation of Pharmacist-Driven Penicillin Allergy Reconciliation
September 17th 2025
- Pharmacists Can Apply Their Expertise to the Medical Psilocybin Act
September 16th 2025
- From Curiosity to Clinical Impact: Shremo Msdi’s Path in Pharmacy Research
September 15th 2025